- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of the European Academy of Dermatology and Venereology, 38, 5, S. 801-811
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2024
- Ereignis
-
Veröffentlichung
- (wer)
-
Wiley
- (wann)
-
2024
- Urheber
-
Faye, Ousmane
Flohr, Carsten
Kabashima, Kenji
Ma, Lin
Paller, Amy S.
Rabenja Rapelanoro, Fahafahantsoa
Steinhoff, Martin
Su, John C.
Takaoka, Roberto
Wollenberg, Andreas
Weng Yew, Yik
Ruiz Postigo, Jose A.
Schmid‐Grendelmeier, Peter
Taïeb, Alain
- DOI
-
10.1111/jdv.19723
- URN
-
urn:nbn:de:bvb:384-opus4-1128270
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Faye, Ousmane
- Flohr, Carsten
- Kabashima, Kenji
- Ma, Lin
- Paller, Amy S.
- Rabenja Rapelanoro, Fahafahantsoa
- Steinhoff, Martin
- Su, John C.
- Takaoka, Roberto
- Wollenberg, Andreas
- Weng Yew, Yik
- Ruiz Postigo, Jose A.
- Schmid‐Grendelmeier, Peter
- Taïeb, Alain
- Universität Augsburg
- Wiley
Entstanden
- 2024
Ähnliche Objekte (12)
A concept for integrated care pathways for atopic dermatitis — a GA2LEN ADCARE initiative
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Severe atopic dermatitis in early infancy: characteristics, challenges and new perspectives in clinical practice
Unraveling the complexity of atopic dermatitis: the CK‐CARE approach toward precision medicine
Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis
Essential aspects of atopic dermatitis
FDI and unemployment, a growth perspective
S3 guideline Atopic dermatitis: part 2 ‐ systemic treatment
Are health care scams infectious? Empirical evidence on contagion in health care fraud
Stress, personal control and health
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity
Stakeholder theory and the knowledge problem : A Hayekian perspective
A concept for integrated care pathways for atopic dermatitis — a GA2LEN ADCARE initiative
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Severe atopic dermatitis in early infancy: characteristics, challenges and new perspectives in clinical practice
Unraveling the complexity of atopic dermatitis: the CK‐CARE approach toward precision medicine
Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis
Essential aspects of atopic dermatitis
FDI and unemployment, a growth perspective
S3 guideline Atopic dermatitis: part 2 ‐ systemic treatment
Are health care scams infectious? Empirical evidence on contagion in health care fraud
Stress, personal control and health
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity
Stakeholder theory and the knowledge problem : A Hayekian perspective
A concept for integrated care pathways for atopic dermatitis — a GA2LEN ADCARE initiative
Update "Systemic treatment of atopic dermatitis" of the S2k‐guideline on atopic dermatitis
Severe atopic dermatitis in early infancy: characteristics, challenges and new perspectives in clinical practice
Unraveling the complexity of atopic dermatitis: the CK‐CARE approach toward precision medicine
Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis
Essential aspects of atopic dermatitis
FDI and unemployment, a growth perspective
S3 guideline Atopic dermatitis: part 2 ‐ systemic treatment
Are health care scams infectious? Empirical evidence on contagion in health care fraud
Stress, personal control and health
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity